Healthcare Services

Opioid Use Disorder (OUD) Market Dynamics 2026: Future Outlook and Key Insights

February 27, 2026April 15, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the opioid use disorder (oud) market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Opioid Use Disorder (OUD) Market expected to reach by 2030?

The market size for opioid use disorder (OUD) has experienced substantial growth in recent years. This market is expected to increase from $4.37 billion in 2025 to $4.89 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.8%. The reasons for its historical expansion include the overprescription of opioid painkillers, an increasing prevalence of chronic pain conditions, limited access to early addiction treatment, the social stigma surrounding substance abuse treatment, and the growing availability of illicit opioids.

The opioid use disorder (OUD) market is projected to experience substantial expansion over the upcoming years, with an anticipated growth to $7.82 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.5%. This expansion during the forecast period can be attributed to enhanced government investment in addiction treatment initiatives, broader acceptance of medication-assisted treatment, the expansion of online and telehealth services for addiction, increased insurance coverage for OUD treatments, and a heightened emphasis on strategies for prevention and harm reduction. Key trends emerging in this period involve the increasing uptake of medication-assisted treatment programs, a greater integration of behavioral therapy with medication-based care, the proliferation of community-based opioid treatment facilities, a stronger focus on long-acting injectable treatments for OUD, and an amplified commitment to preventing relapse and supporting long-term recovery.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12586&type=smp

What Drivers Are Driving Adoption Within The Opioid Use Disorder (OUD) Market?

The increasing prevalence of opioid addiction is anticipated to drive the expansion of the opioid use disorder (OUD) market in the future. Opioid addiction is defined as a medical condition marked by habitual and persistent opioid consumption, leading to detrimental bodily effects. Opioids are capable of inducing euphoria and alleviating pain; however, their ongoing use can result in tolerance, necessitating larger doses for the desired effect, potentially culminating in opioid use disorder. For instance, in 2023, according to the Centers for Disease Control and Prevention, a US-based public health agency, in 2023, the number of drug overdose deaths involving any opioid was 79,358. The rate of drug overdose fatalities linked to any opioid stood at 23.7 per 100,000 population. Consequently, the increasing incidence of opioid addiction is a key factor propelling the expansion of the opioid use disorder (OUD) market.

What Segments Are Included Within The Opioid Use Disorder (OUD) Market?

The opioid use disorder (oud) market covered in this report is segmented –

1) By Drug Type: Buprenorphine, Naltrexone, Methadone

2) By Route Of Administration: Oral, Parenteral

3) By Age Group: 19 To 40, 41 To 60, 61 And Over

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies

Subsegments:

1) By Buprenorphine: Suboxone, Buprenorphine Tablets, Buprenorphine Film

2) By Naltrexone: Naltrexone Tablets, Vivitrol

3) By Methadone: Methadone Tablets, Methadone Oral Solution

What Trends Are Reshaping The Dynamics Of The Opioid Use Disorder (OUD) Market?

Companies operating within the opioid use disorder (OUD) market are concentrating on developing advanced solutions, such as next-generation extended-release buprenorphine formulations. This focus aims to address the increasing need for long-acting, adherence-supporting treatment options that effectively reduce withdrawal symptoms and enhance recovery outcomes. Extended-release buprenorphine formulations deliver sustained medication over weekly or monthly periods, providing increased convenience and stability compared to daily oral or sublingual therapies, which can elevate the risk of relapse. For instance, in May 2023, the U.S. Food and Drug Administration, a US-based federal agency, granted approval to Brixadi (buprenorphine) extended-release injection for treating moderate to severe opioid use disorder (OUD). Brixadi is available in two forms: a weekly injection for patients who started treatment with a single dose of a transmucosal buprenorphine product or are currently taking the medication, and a monthly version for individuals who are already receiving the medication.

Who Are The Top-Performing Companies In The Opioid Use Disorder (OUD) Market In Recent Years?

Major companies operating in the opioid use disorder (oud) market are Indivior Plc., Alkermes Inc., Braeburn Pharmaceuticals Inc., Titan Pharmaceuticals Inc., BioDelivery Sciences International Inc., Camurus AB, Orexo US Inc., Rhodes Pharmaceuticals L P, Mallinckrodt Pharmaceuticals, Hikma Pharmaceuticals Plc., Teva Pharmaceutical Industries Ltd., Viatris Inc., Mylan NV, Adapt Pharma Inc., Opiant Pharmaceuticals Inc., Dr Reddy’s Laboratories Ltd., Cipla Limited, Luye Pharma Group, Amneal Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Knight Therapeutics, BioCorRx Inc., Lannett Company Inc., Zydus Cadila, Apotex Inc., Intas Biopharmaceuticals, Glenmark Pharmaceuticals Ltd., InterveXion Therapeutics

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

How Does The Opioid Use Disorder (OUD) Market Perform Across Major Global Regions?

North America was the largest region in the opioid use disorder (OUD) market in 2025. The regions covered in the opioid use disorder (oud) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Opioid Use Disorder (OUD) Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12586&type=smp

Browse Through More Reports Similar to the Global Opioid Use Disorder (OUD) Market 2026, By The Business Research Company

Migraine Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/migraine-treatment-global-market-report

Opioids Market Report 2026

https://www.thebusinessresearchcompany.com/report/opioids-global-market-report

Opioid Induced Constipation Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/opioid-induced-constipation-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795